Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
      • Neuroimmunology: To Sense and Protect
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

ATP-Mediated Killing of Intracellular Mycobacteria by Macrophages Is a P2X7-Dependent Process Inducing Bacterial Death by Phagosome-Lysosome Fusion

Ian P. Fairbairn, Carmel B. Stober, Dinakantha S. Kumararatne and David A. Lammas
J Immunol September 15, 2001, 167 (6) 3300-3307; DOI: https://doi.org/10.4049/jimmunol.167.6.3300
Ian P. Fairbairn
Medical Research Council Centre for Immune Regulation, Birmingham Medical School, Birmingham University, Edgbaston, Birmingham, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carmel B. Stober
Medical Research Council Centre for Immune Regulation, Birmingham Medical School, Birmingham University, Edgbaston, Birmingham, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dinakantha S. Kumararatne
Medical Research Council Centre for Immune Regulation, Birmingham Medical School, Birmingham University, Edgbaston, Birmingham, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David A. Lammas
Medical Research Council Centre for Immune Regulation, Birmingham Medical School, Birmingham University, Edgbaston, Birmingham, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Mycobacterium tuberculosis survives within host macrophages by actively inhibiting phagosome fusion with lysosomes. Treatment of infected macrophages with ATP induces both cell apoptosis and rapid killing of intracellular mycobacteria. The following studies were undertaken to characterize the effector pathway(s) involved. Macrophages were obtained from p47phox and inducible NO synthase gene-disrupted mice (which are unable to produce reactive oxygen and nitrogen radicals, respectively) and P2X7 gene-disrupted mice. RAW murine macrophages transfected with either the natural resistance-associated macrophage protein gene 1 (Nramp1)-resistant or Nramp1-susceptible gene were also used. The cells were infected with bacille Calmette-Guérin (BCG), and intracellular mycobacterial trafficking was analyzed using confocal and electron microscopy. P2X7 receptor activation was essential for effective ATP-induced mycobacterial killing, as its bactericidal activity was radically diminished in P2X7−/− macrophages. ATP-mediated killing of BCG within p47phox−/−, inducible NO synthase−/−, and Nramps cells was unaffected, demonstrating that none of these mechanisms have a role in the ATP/P2X7 effector pathway. Following ATP stimulation, BCG-containing phagosomes rapidly coalesce and fuse with lysosomes. Blocking of macrophage phospholipase D activity with butan-1-ol blocked BCG killing, but not macrophage death. ATP stimulates phagosome-lysosome fusion with concomitant mycobacterial death via P2X7 receptor activation. Macrophage death and mycobacterial killing induced by the ATP/P2X7 signaling pathway can be uncoupled, and diverge proximal to phospholipase D activation.

Approximately one-third of the world’s population is infected with Mycobacterium tuberculosis, yet 90% of infected individuals remain healthy (1). Of these, <10% will exhibit reactivation disease within their lifetime. Therefore, in the vast majority of individuals, their immune systems can effectively control the infection.

From HIV patients (2) and certain rare immunodeficient individuals (3, 4), we know that human immunity to mycobacterial infections constitutes an interplay between Ag-specific CD4+ Th1 lymphocytes and host macrophages. The macrophages promote Th1 activity by production of IL-12 (3), IL-18 (5), and IL-23 (6), and the lymphocytes activate macrophages through the release of IFN-γ (4) and TNF-α (7). These two sets of effector cells are then thought to interact in a positive feedback manner to contain the infection within T cell-activated macrophages.

Mycobacteria, in turn, are thought to survive and replicate within nonactivated macrophages through a variety of strategies, including the avoidance of generation of reactive oxygen (8) and nitrogen intermediates (9) and the active inhibition of phagosome maturation (10, 11). The latter strategy preventing exposure to the antimicrobial peptides and enzymes presents within the acidic lysosomal granules. Infected cells are thought to become progressively unresponsive to further activation by Th1-derived cytokines as the pathogen undergoes intracellular replication (12).

Innate resistance to intracellular infections is also thought to be genetically determined, influencing the outcome of infection. The best characterized is the natural resistance-associated macrophage protein gene 1 (Nramp1)3 (13). This gene codes for a membrane transporter protein that acts to inhibit the replication of various intracellular pathogens, including bacille Calmette-Guérin (BCG), by excluding Fe2+ (14, 15) and other cations from the pathogen-containing phagosomes and promoting its acidification (16).

The macrophage acts as both the major reservoir of infection and the principal effector cell acting to regulate mycobacterial infections in vivo.

A major drawback in our understanding of the effector pathway(s) operating within human macrophages is the fact that, unlike in murine model cell systems (17), no mycobactericidal effect is observed in vitro following stimulation of macrophages with Th1-associated cytokines, including IFN-γ and TNF-α (18). This has been attributed to the inability of such mediators to induce NO generation in human cells. However, we know that in vivo macrophages are able to contain these organisms in the vast majority of infected individuals. This has initiated a search for alternative stimuli that may regulate mycobacteristatic or mycobactericidal activity within infected human cells.

We have previously reported that a 15-min exposure to 1–3 mM ATP results in the apoptosis of BCG-infected monocyte-derived human macrophages within 6 h, with a concomitant 50–70% reduction in the viability of intracellular mycobacteria. ATP treatment of a macrophage-free culture of BCG had no effect on bacterial viability, demonstrating this to be a cell-mediated mechanism (19). Virulent strains of tuberculosis were also found to be equally as susceptible to this mechanism (20).

The effects of ATP were shown to be mediated by P2X7 receptors, as the cytocidal and bactericidal activity of ATP were blocked by pretreatment of cells with P2X7 antagonists, oxidized ATP, and KN62, and potentiated by the specific agonist benzoyl-benzyl ATP (19).

We have shown previously that the mycobactericidal effects of ATP are independent of both reactive oxygen and nitrogen intermediate generation. ATP was found to be equally effective on cells derived from patients with chronic granulomatous disease as against cells from healthy controls. Furthermore, BCG killing occurred even when such cells were additionally treated in vitro with NO inhibitors (19).

Electron microscopy (EM) studies have revealed that ATP-induced cell death of BCG-infected human macrophages is associated with the formation of cytoplasmic vacuoles into which the intracellular bacteria coalesce (21). This was thought to illustrate the promotion of phagosome-lysosome fusion and/or modulation of the phagosome pH within ATP-treated cells, resulting in the destruction of the mycobacteria.

In this study, we report the use of macrophages derived from various gene-disrupted (knockout) mice to further characterize the ATP effector mechanism involved and to confirm the selective involvement of the P2X7 receptor in this mycobactericidal effect. Using EM and confocal fluorescent microscopy, we have further analyzed the multibacillary vacuole formation that occurs following ATP stimulation. Our findings suggest these play a critical role in mediating the death of mycobacteria as they progressively acidify and fuse with cell lysosomes. Finally, we also demonstrate a key role for phospholipase D (PLD) in the P2X7 effector pathway, supporting similar findings reported by Kusner et al. (20).

Materials and Methods

Cells and bacteria

The murine macrophage cell line J774a.1 was obtained from the American Type Culture Collection (Manassas, VA). The cells were cultured in DMEM (Life Technologies, Paisley, U.K.) supplemented with 10% FCS and 2 mM glutamine. The murine macrophage cell lines RAW 246.7, wild-type (WT) RAW 7.5R, and RAW 10S were a kind gift from J. M. Blackwell (Cambridge University, Cambridge, U.K.). The 7.5R and 10S lines are stable transfectants, the generation of which has been described previously (22). These were cultured in RPMI (Life Technologies) supplemented with 10% FCS and 2 mM glutamine. P2X7−/−, p47phox−/−, and inducible NO synthase (iNOS)−/− mice were kind gifts from I. P. Chessell (Glaxo Wellcome, Cambridge, U.K.), A. W. Segal (University College of London, London, U.K.), and F. Y. Liew (University of Glasgow, Glasgow, U.K.), respectively, and have been previously described (23, 24, 25). The genetic backgrounds of these knockout mice were, respectively, C57/129, C57, and 129. WT C57BL/6 and 129 were used as controls, as appropriate. Bone marrow-derived macrophages (BMDMs) were obtained as follows. Femurs and tibias were flushed with DMEM, and the bone marrow was washed and plated out overnight in DMEM supplemented with 10% FCS, 10% GM-CSF-containing medium, and 2 mM glutamine. Nonadherent cells were then removed, washed, and plated at 106/ml in the above medium. The cells were cultured for a further 9 days, with changes of the medium on days 3 and 6. On day 9, the cells were adherent and morphologically looked like mature macrophages.

M. bovis BCG Evans strain was obtained from Evans Medical (Speke, U.K.) and maintained in log phase growth in 7H9 broth supplemented with 10% albumin dextrose catalase (ADC) enrichment medium and 0.2% Tween 80. Green fluorescent protein expressing BCG (GFP-BCG) was a kind gift from D. Young (Imperial College of London, London, U.K.). These contained the gene encoding a FACS-optimized GFP protein (26) constitutively expressed under the control of the mycobacterial heat shock protein 60 promoter in a pSMT3 shuttle vector (27) construct. Stock aliquots, stored in glycerol at −70°C, were grown to log phase in 7H9 broth supplemented with 10% ADC enrichment medium, 0.2% Tween 80, and 50 μg/ml hygromycin (Sigma, St. Louis, MO).

BCG viability assay

Macrophages were grown to subconfluence in 200 μl/well cultures in 96-well round-bottom microtiter plates. This approximates to 5 × 104 cells in 200 μl/well. A total of 5 × 105 BCG Evans per well was added. To aid infection, plates were centrifuged at 700 × g for 10 min and incubated at 37°C for 60 min. Excess BCG were removed by washing. As assessed by CFU, ∼10% of BCG was taken up, giving a ratio of one viable BCG per macrophage. Where appropriate, the following metabolic inhibitors were then added for 60 min. NG-Monomethyl-L-arginine monoacetate (L-NMMA) (400 μM), superoxide dismutase (15 U/ml), catalase (0.1 mg/ml), and butan-1-ol (0.05–1%) were all purchased from Sigma. A 30 mM ATP (Boehringer Mannheim, Indianapolis, IN) solution was prepared in culture medium, adjusted to pH 7 with sodium bicarbonate, and passed through a 0.22-μM filter (Millipore, Bedford, MA) to sterilize. It was added to the macrophage cultures to give a final concentration 3 mM, and incubated at 37°C, 5% CO2. At appropriate time points, the plates were centrifuged at 700 × g for 10 min. A total of 150 μl supernatant was removed and replaced with 130 μl 7H9 medium, supplemented as above, plus 20 μl 2% saponin solution. Cell lysis was promoted by vigorous pipetting and then incubation at 37°C for 120 min. Fifty-microliter aliquots from each well were serially diluted in 7H9 supplemented with 10% ADC enrichment and 0.2% glycerol and plated in 96-well flat-bottom plates. The plates were then incubated at 37°C for 12 days. Microcolonies were counted using an inverted microscope (×100 magnification). All experiments were performed in quadruplets.

Lucifer yellow uptake

Pore formation was assessed using a method adapted from that described by Steinberg et al. (28). Briefly, macrophages adherent to coverslips were incubated with 500 μg/ml lucifer yellow dye, 250 μM sulfinpyrazone (Sigma), and 3 mM ATP in PBS for 5 min. They were washed in 250 μM sulfinpyrazone in PBS and viewed immediately on a Zeiss confocal laser-scanning microscope (Zeiss, Oberkochen, Germany). Cells with pores larger than 463 Da exhibit intracellular staining.

Chromium-release assay

Mouse BMDMs were cultured in 96-well round-bottom microtiter plates, as previously described. Aliquots of 51Cr (ICN Pharmaceuticals, Costa Mesa, CA) were added at a concentration of 2 μCi/well, and the plates were incubated for 16 h. Cells were washed and incubated with 3 mM ATP for a further 16 h. Supernatants were removed, and their activity was counted on a Wallac 1260 Multi Gamma II gamma counter (PerkinElmer Wallac, Gaithersburg, MD). The cells themselves were dissolved in 1% Triton X-100 solution and also counted. Results are expressed as the percentage of the total activity in the supernatant.

Confocal fluorescent microscopy

Macrophages were grown to subconfluence on 13-mm glass coverslips in 24-well plates. This approximated to 5 × 105 cells/coverslip. GFP-BCG were resuspended in DMEM, and a single cell culture was prepared by water bath sonication for 5 min. Any remaining clumps were removed by slow speed centrifugation (100 × g for 5 min). The bacterial concentration and confirmation of a single cell suspension were determined using a thoma chamber. The BCG were then added to the macrophages to give a final concentration of 2.5 × 107/coverslip. The plate was centrifuged at 700 × g for 10 min. The cells were incubated for 1 h at 37°C, 5% CO2, washed three times in DMEM to remove any extracellular bacteria, and incubated for an additional hour at 37°C, 5% CO2.

LysoTracker (Molecular Probes, Eugene, OR) was added to the cells (final concentration of 50 nM) for 1 h before stimulation. ATP was then added (final concentration of 3 mM), and the cells were incubated for the indicated times.

Before fixation, coverslips were washed three times in HBSS (Sigma). They were then fixed in 3% paraformaldehyde containing 10 mM lysine, 140 mM saline, and 40 mM HEPES (pH 7.3) for 15 min at room temperature. After washing in PBS plus 5% dextrose, the coverslip cultures were mounted on glass slides with Perma Fluor (Lipshaw Manufacturing, Detroit, MI), and the edges were sealed with nail varnish.

Slides were viewed with a Zeiss confocal laser-scanning microscope. Twenty fields were examined per slide, and representative pictures were taken.

Electron microscopy

The 3-(2,4-dinitroanilino)-3′-amino-N-methyl dipropylamine (DAMP; Molecular Probes) staining was adapted from Crowle et al. (29). BMDMs were cultured as described above on 13-mm plastic coverslips and infected with BCG Evans at an infection ratio of 5 BCG to 1 macrophage. ATP (3 mM final) was then added, and 30 min before the end of the experiment DAMP (50 μM final) was also added. The coverslips were washed three times in PBS and fixed in 2% gluteraldehyde in 0.1 M calcodylate and 2.5% sucrose (pH 7.35) for 60 min at 4°C. They were washed in 50 mM ammonia chloride, and then progressively dehydrated in ethanol, infiltrated with London Resin white (Agar Scientific, Stanstead, U.K.), and polymerized with UV light. Ultrathin sections were collected on nickel grids, which were incubated for 10 min with 0.1 M HCl. These were then blocked with 0.2% BSA and 0.2% goat serum in PBS for 45 min at room temperature. The primary Ab was a mouse antidinitrophenol monoclonal (NovoCastra, Newcastle, U.K.). A mouse IgG1 control Ab (BD PharMingen, San Diego, CA) was also used to exclude nonspecific staining. These were added at a concentration of 0.5 ng/ml for 16 h at 4°C. The secondary was a goat antimouse polyclonal Ab conjugated to 5 nM gold particles (British Biocell International, Cardiff U.K.). This was used at a dilution of 1/50 and incubated with the cells for 90 min at room temperature. Grids were counterstained with urinyl acetate and viewed on a Joel Temscan (Wellwyn Garden City, U.K.) electron microscope. Pictures were taken on Agfa Scientia (Agar Scientific) EM film. The number of gold particles per vacuole was counted. Counts were performed for 20 vacuoles, involving at least 10 macrophages for each experiment.

Statistics

The Student’s t test was used for all statistical analysis.

Results

Macrophage BCG killing kinetics post-ATP stimulation

ATP stimulation of BCG-infected J774 cells resulted in ∼50% loss of mycobacterial CFU within 60 min posttreatment (Fig. 1⇓). Loss of mycobacterial viability was detectable within 15 min and maximal at 2 h posttreatment. Subsequently, all viability studies were performed at 2 h post-ATP stimulation.

FIGURE 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1.

BCG viability post-ATP stimulation of J774 macrophages. Macrophages of the murine cell line J774 were infected with BCG for 60 min. Extracellular BCG were washed off, and the macrophages were then stimulated with 3 mM ATP. After the indicated time, they were lysed and assayed for BCG CFU. The time course shows rapid cell death within 15 min, with a maximum response within 60 min. SDs for quadruplets are shown, and the results are representative of three experiments. Similar results were found with human monocyte-derived macrophages, RAW macrophages, and BMDMs from BALB/c, C57BL/6, and 129 mice.

Similar BCG killing kinetics was observed in another murine macrophage cell line (RAW), and with the human monocyte cell line (THP-1), and in murine BMDMs from various mouse strains (C57BL/6, BALB/c, and 129) (results not shown).

The ATP/P2X7 effector mechanism was confirmed as a cell-mediated function, as ATP had no effect on BCG grown in macrophage-free cultures (results not shown).

ATP-mediated pore formation and macrophage death are P2X7 dependent

BMDMs from P2X7−/− mice were examined for their responses following ATP stimulation. Cells from WT mice were shown to rapidly take up the cell-impermeable dye lucifer yellow following treatment with ATP for 5 min, indicating P2X7 pore formation had occurred (Fig. 2⇓, A and B), whereas cells from P2X7−/− mice failed to do so (Fig. 2⇓, C and D). WT BMDMs were also shown to die in response to ATP stimulation over a 16-h period, as indicated by 51Cr release, whereas macrophages from P2X7−/− mice remained viable (Fig. 3⇓a).

FIGURE 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2.

Macrophage membrane permeabilization following ATP stimulation. Macrophages were cultured from the bone marrow of P2X7−/− mice and WT littermates. They were stimulated with 3 mM ATP for 5 min in the presence of the cell-impermeable dye lucifer yellow. The cells were then washed and immediately viewed with confocal fluorescent (A and C) and transmission (B and D) microscopy. A and B demonstrate stimulated WT macrophages that are permeable to the dye, whereas C and D demonstrate stimulated macrophages from P2X7−/− mice whose membranes have remained impermeable. The pictures are representative of numerous fields from three experiments.

FIGURE 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 3.

a, Chromium release post-ATP stimulation of P2X7−/− BMDMs. b, Intracellular BCG killing by ATP-stimulated P2X7−/− BMDMs. BMDMs were cultured from P2X7−/− mice and WT littermates. a, Macrophages were labeled overnight with 51Cr. Excess chromium was removed. Where indicated, they were then stimulated for 16 h with 3 mM ATP. γ Activity was counted in both the supernatant and cells. Results are expressed as percentage released over total. SDs for quadruplets are shown, and the results are representative of three experiments. After stimulation, the amount of chromium released by the WT macrophages increases, indicating that cell death had occurred. There was no response in the P2X7−/− macrophages. b, The macrophages were infected with BCG for 60 min, and extracellular BCG were washed off. Where appropriate, macrophages were stimulated with 3 mM ATP for 120 min. They were then lysed and assayed for BCG CFU. The percentage of intracellular BCG killed is calculated by comparing the CFU from stimulated with the CFU from unstimulated macrophages. SDs for four experiments, each done in quadruplet, are shown. WT, but not P2X7−/−, macrophages are effective at killing BCG.

ATP-mediated killing of intracellular mycobacteria is P2X7 dependent

Having demonstrated that macrophages from P2X7−/− mice had no P2X7-associated cytotoxic activity, they were then assessed for their ability to kill intracellular mycobacteria following ATP stimulation. BMDMs were infected with BCG and exposed to ATP (3 mM) for 2 h. Compared with WT cells, macrophages from P2X7−/− mice were shown to be ineffective at killing BCG (Fig. 3⇑b). The percentage of BCG killed was reduced from 50% in ATP-treated WT cells to <10% in P2X7−/− cells. Although some residual mycobactericidal activity was still occurring, the results show that P2X7 is the primary transducer of the intracellular mycobactericidal effector pathway activated following ATP stimulation of infected macrophages.

PLD activity is essential for ATP/P2X7-mediated BCG killing, but not macrophage death

PLD is involved in a number of signaling cascades via the production of phosphatidic acid from phosphorylcholine. If cells are pretreated with butan-1-ol, PLD preferentially uses the primary alcohol as a substrate producing the nonsignaling phosphatidyl butanol (30). Treatment with butan-1-ol after BCG infection, but before ATP stimulation, showed a concentration-dependent inhibition of BCG killing post-ATP (Fig. 4⇓a), but had no effect on macrophage death, as measured by chromium release (Fig. 4⇓b).

FIGURE 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 4.

a, Effect of PLD inhibition on BCG killing by J774 macrophages post-ATP stimulation. J774 macrophages were infected with BCG and then treated for 60 min with the indicated concentrations of butan-1-ol to inhibit PLD activity. They were then stimulated with 3 mM ATP for 2 h. BCG viability was assessed and expressed as percentage of BCG killed. Inhibition of PLD activity completely inhibits BCG killing. SDs for quadruplets are shown, and the results are representative of three experiments. b, Effect of PLD inhibition on macrophage death post-ATP stimulation. 51Cr-labeled macrophages were pretreated with the indicated concentrations of butan-1-ol for 60 min before 16-h stimulation with 3 mM ATP. Inhibition of PLD activity has no effect on macrophage death. SDs for quadruplets are shown, and the results are representative of three experiments.

Radical oxygen intermediates and radical nitrogen intermediates are not required for BCG killing post-ATP/P2X7 stimulation

Experiments were performed to investigate whether the ATP-induced mycobactericidal effects observed in murine macrophages were attributable to the generation of reactive oxygen or reactive nitrogen intermediates.

The high levels of NO required for killing mycobacteria within murine macrophages are generated by the enzyme iNOS after appropriate priming and stimulation of the cells. Macrophages from iNOS−/− mice are therefore unable to up-regulate nitrogen radical production (25). p47phox is a key enzyme in the NADPH reductase pathway, and mice with a targeted disruption of this gene are unable to produce reactive oxygen radicals (24).

BMDMs from iNOS−/− and p47phox−/− mice and WT littermates were infected with BCG and treated with ATP (3 mM) for 2 h. The results (Fig. 5⇓) reveal that ATP was equally effective in inducing bacterial death within iNOS−/− and p47phox−/− macrophages as in WT cells.

FIGURE 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 5.

Intracellular BCG killing by BMDMs does not require oxygen or nitrogen radicals. BMDMs were cultured from p47phox−/−, iNOS−/−, and WT littermates. They were infected with BCG before being stimulated with 3 mM ATP for 2 h. BCG viability was assessed by CFU. Results are expressed as percentage of BCG killed. Where indicated, 400 μM L-NMMA, 15 U/ml superoxide dismutase, or 0.1 mg/ml catalase was added 60 min before stimulation. SDs for quadruplets are shown, and the results are representative of two to three experiments. In all scenarios, the macrophages remained effective at killing BCG, indicating that neither nitrogen nor oxygen radicals are required.

To confirm that production of neither oxygen or nitrogen radicals was required for the ATP effect, nitrogen radical production was blocked in the p47phox−/− macrophages using the NO inhibitor L-NMMA, and oxygen radical production was blocked in the iNOS−/− macrophages using superoxide dismutase and catalase (Fig. 5⇑). ATP killing of BCG was shown to be equally as effective in all cell treatments. The data reveal that oxygen and nitrogen radicals do not have a role in the ATP effector mechanism.

Killing post-P2X7 stimulation is not affected by Nramp1 genotype

The susceptibility of inbred mice strains to BCG is associated with a single point mutation of Nramp1 (31). Both the RAW and J774 macrophage cell lines are derived from BALB/c mice, which carry the susceptible mutation of Nramp1 (31).

To examine the possible influence of Nramp1 on the ATP-bacterial killing effect, RAW cells, stably transfected with either the resistant Nramp1 (RAW 7.5R) or the susceptible Nramp1 (RAW 10S), were used. ATP treatment of BCG-infected 7.5R and 10S cells was shown to be equally as effective in inducing killing of BCG, as was observed in the WT RAW cells (Fig. 6⇓). This indicates that expression of Nramp1 does not affect the ability of RAW cells to kill BCG in response to ATP stimulation.

FIGURE 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 6.

ATP-stimulated killing of BCG by RAW macrophages transfected with resistant or susceptible Nramp1. The 7.5R and 10S RAW macrophages, which have been respectively transfected with the resistant and susceptible Nramp1 genes, were infected with BCG and stimulated with 3 mM ATP for 2 h. BCG viability was assessed by CFU and expressed as the percentage of BCG killed. Ability to kill post-ATP is independent of which Nramp1 gene has been transfected. SDs for quadruplets are shown, and the results are representative of three experiments.

Further support for this finding is provided by the observation that BMDMs from BALB/c, C57BL/6, and 129 mice were all equally effective at killing intracellular mycobacteria following ATP stimulation. BALB/c and C57BL/6 mice are known to be susceptible to BCG infection and carry the susceptible Nramp1 mutation, whereas 129 mice are a resistant strain and carry the resistant gene (31). In total, the data suggest that Nramp1 does not have a role in ATP-mediated killing of intracellular mycobacteria.

BCG-containing phagosomes fuse with lysosomes post-P2X7 stimulation: confocal fluorescent microscopy studies

Mycobacteria survive within macrophages by inhibiting the maturation of their phagosomes, thus avoiding fusion with lysosomes (10). Lysosomes provide a potentially toxic environment for mycobacteria containing various hydrolases and cationic proteins in an acidic environment. The promotion of phagosome-lysosome fusion by ATP was therefore investigated as a potential mycobacterial-killing mechanism.

Confocal fluorescent microscopy was used to show that P2X7 stimulation of infected BMDMs resulted in the rapid fusion of the BCG-containing phagosomes with lysosomes (Fig. 7⇓). The acidophilic dye LysoTracker (Molecular Probes) was used to prelabel the cell lysosomes red, and GFP-BCG were used to infect the BMDMs. When analyzed by confocal fluorescent microscopy, the BCG in non-ATP-treated cells (Fig. 7⇓, A and B) appeared green, indicating that they were residing in nonacidic vesicles separate from the red-staining lysosomes. However, in ATP-treated cells (Fig. 7⇓, C and D), an increasing percentage of the BCG appeared yellow (due to colocalization with the red LysoTracker), indicating that they were residing within acidic organelles that had fused with lysosomes. To quantify the colocalization of the BCG, serial observations were expressed as the percentage of colocalized BCG over total intracellular BCG (Fig. 8⇓). The results illustrate the progressive acidification of the BCG-containing phagosomes. These experiments show that BCG-containing phagosomes rapidly fuse with lysosomes following ATP stimulation.

FIGURE 7.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 7.

Confocal fluorescent microscopy images showing BCG and lysosome localization. Confocal fluorescent (A, C, and E) and transmission (B, D, and F) microscopy of macrophages infected with GFP-BCG and incubated with LysoTracker to stain lysosomes red. A and B, An unstimulated macrophage containing a green BCG separate from the red lysosomes. C and D, A macrophage that has been stimulated for 240 min with 3 mM ATP. The intracellular BCG now appear yellow, indicating that colocalization and phagosome-lysosome fusion have occurred. The extracellular BCG remains green. E and F, A P2X7−/− macrophage that has been stimulated with ATP. No colocalization has occurred. Representative pictures from at least three experiments are shown.

FIGURE 8.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 8.

Colocalization between intracellular, BCG, and lysosomes following ATP stimulation. The results from experiments similar to those that gave the images shown in Fig. 7⇑ were quantified. BCG that appeared yellow were said to be colocalized and expressed as a percentage of total intracellular BCG. Over 200 BCG from at least 30 macrophages and three different experiments were assessed. SDs are shown. Increasing colocalization after ATP stimulation is demonstrated.

Experiments using UTP, GTP, and AMP failed to show phagosome-lysosome fusion (results not shown), suggesting that ATP was acting via the P2X7 receptor. In addition, phagosome-lysosome fusion was absent in ATP-stimulated P2X7−/− macrophages (Fig. 7⇑, E and F). The data demonstrate that the phagosome-lysosome fusion that occurs following ATP stimulation is dependent on and is a function of P2X7 activation.

BCG-containing phagosomes fuse to form acidified multibacillary vacuoles post-P2X7 stimulation: EM studies

High resolution transmission EM was used to investigate the morphological changes accompanying the fusion of BCG-containing phagosomes with lysosomes following ATP stimulation. ATP-induced acidification of BCG-containing phagosomes was confirmed by the prestaining of cells with DAMP, an acidophilic dye that has a preferential affinity for acidic organelles such as lysosomes. DAMP staining was then detected using a gold-labeled anti-dinitrophenol Ab. Fig. 9⇓, A and B, illustrates a non-ATP-stimulated macrophage in which the BCG-containing phagosome has little to no gold labeling, and is therefore shown not to be acidic. This supports previous findings (10, 11, 32) that BCG normally reside within individual nonacidic phagosomes that do not fuse with lysosomes. Within 30 min of ATP stimulation, marked changes could be observed within infected macrophages (Fig. 9⇓, C and D). At low power (×5000), the BCG were observed to coalesce into multibacillary vacuoles (Fig. 9⇓C). These are heavily labeled with DAMP (Fig. 9⇓D), indicative of vacuole acidification, in contrast to the non-DAMP-labeled individual BCG-containing phagosomes seen in unstimulated cells.

FIGURE 9.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 9.

EM studies of BMDMs infected with BCG and stimulated with ATP. BMDMs were cultured from P2X7−/− mice and WT littermates. They were infected with BCG and, where indicated, stimulated with ATP. Before fixation, cells were incubated with DAMP that localizes to acidic organelles. The DAMP was then gold labeled. A, C, and E, Magnification, ×5,000; B and F, ×50,000; and D, ×40,000. A and B, An unstimulated macrophage. BCG reside in individual phagosomes that are not gold labeled, indicating they are not acidic. C and D, A macrophage that has been stimulated with 3 mM ATP for 30 min. The BCG-containing phagosomes have coalesced, and the resulting vacuole shown in D is heavily gold labeled, indicating it is acidic. E and F, A macrophage from a P2X7−/− mouse after ATP stimulation for 30 min. The BCG-containing phagosomes have neither coalesced nor acidified. Representative pictures from at least three experiments are shown.

By counting the number of gold particles per vacuole, the amount of DAMP staining in the various phagosomes/vacuoles was quantified (Fig. 10⇓). Overall, the results confirm and illustrate the rapid acidification of phagosomes that occurs post-ATP stimulation. In addition, the EM studies illustrate that this involves the fusion of individual BCG-containing phagosomes both with each other and with lysosomes.

FIGURE 10.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 10.

Acidity of BCG-containing vacuoles in ATP-stimulated J774 macrophages. Electron micrographs were prepared as in Fig. 9⇑. BCG-infected J774 macrophages were stimulated with 3 mM ATP for the indicated times. The number of gold particles per BCG-containing phagosome or vacuole is proportional to its acidity.

To confirm that the formation of acidified multibacillary vacuoles was specifically due to ATP stimulation of P2X7 receptors, the EM study was repeated using cells derived from P2X7−/− mice. Fig. 9⇑, E and F, illustrates that at 2 h post-ATP stimulation of P2X7−/− BMDMs, the BCG-containing phagosomes have neither acidified nor coalesced.

Discussion

In this study, loss of intracellular BCG viability was shown to occur within 15 min following ATP stimulation of infected murine macrophages. The rapidity of the effect excluded a role for either nutrient and/or iron deprivation as the antimycobacterial mechanism responsible. The speed of the bactericidal activity indicates the involvement of a preformed toxic mediator that does not require de novo synthesis. This is in agreement with our previous findings, in which we showed that the protein synthesis inhibitor cycloheximide was unable to block ATP-induced BCG killing (19).

The kinetics of ATP-induced BCG killing was more rapid than induction of cell death. However, although ATP-stimulated cell death and BCG killing were both shown to be specifically P2X7 dependent, their effector signaling pathways were found to diverge downstream of P2X7 activation. Blocking of cellular PLD activity with butan-1-ol then inhibited BCG killing, but not macrophage death in response to ATP stimulation.

The P2X7 receptor (formally known as P2Z) is highly expressed on cells of the immune system, predominately cells of monocytic lineage (33). However, macrophages are thought to express a number of additional purinergic receptors, including: P2Y1,2,4,5,6,10,11 and P2X1,4,5,7 (34), some of which can respond to ATP with varying sensitivity.

The fact that P2X7−/− macrophages are unable to effectively kill BCG in response to ATP demonstrates unequivocally that P2X7 is the major receptor involved in this specific effector pathway. However, we also observed a small, but nonsignificant level of residual BCG killing within ATP-treated P2X7−/− cells. This is in agreement with Kusner et al. (20), who noted that ATP was slightly more effective than the more specific P2X7 agonist benzoyl-benzyl ATP. Taken together, these findings indicate the possible involvement of an additional purinergic receptor that may contribute to the loss of bacterial viability seen in ATP-treated cells. We have provisionally characterized this additional purine receptor as P2Y11 (35).

Crossover studies using inhibitors to block both nitrogen radical production in p47phox−/− BMDMs and oxygen radical production in iNOS−/− BMDMs also demonstrated unequivocally that neither oxygen nor nitrogen radicals have a role in ATP killing of intracellular BCG. This confirms our previous findings, which showed that monocyte-derived macrophages from patients with chronic granulomatous disease are able to effectively kill BCG following ATP stimulation, and that the addition of the nitrogen radical inhibitor L-NMMA was also unable to inhibit ATP-mediated BCG killing in these cells (19).

Nramp1 is an important mechanism in murine defenses against various intracellular infections including BCG, and has been reported to be associated with human resistance to tuberculosis (36). Nramp1 is also known to be expressed on phagosome membranes (37), and has been proposed to play a role in both iron transport and phagosome acidification (16). In this study, Nramp1 was not found to be involved in the ATP-induced mycobactericidal effector process, as macrophages with either the susceptible or resistant form of the Nramp1 allele were shown to be equally capable of killing intracellular BCG following ATP stimulation.

The molecular probes LysoTracker and DAMP are weak bases that are used to study phagosome acidification because they are selectively taken up within cells by acidic organelles. In this study, both LysoTracker and DAMP preferentially targeted BCG-containing phagosomes following ATP stimulation of infected macrophages, indicating that phagosome-lysosome fusion had occurred. EM studies using DAMP labeling also illustrated that the BCG-containing phagosomes both acidified and fused with each other following ATP stimulation. This is in agreement with Molloy et al. (21), who also reported similar fusion of mycobacteria-containing phagosomes following ATP treatment.

Importantly, the phagosome acidification and phagosome fusion induced by ATP were not seen in BMDMs from P2X7 gene-disrupted mice. This illustrates that, like BCG killing, these fusion processes occur downstream of P2X7 activation.

There was an observed temporal relationship between ATP-induced phagosome acidification and BCG killing that supports the hypothesis that ATP-induced phagosome-lysosome fusion directly results in killing of the intracellular BCG. It is known that mycobacteria grow poorly in acidic environments (38) and the growth rate of intracellular M. tuberculosis is impaired when they enter large acidified vacuoles formed by coinfection with other intracellular organisms (39). Fusion with lysosomes would then expose the BCG to the detrimental effects of low pH and to the toxic actions of lysosomal proteases and antibacterial peptides. The rapid killing effect of ATP observed in this study would suggest that exposure to these lysosomal mediators results in swift mycobactericidal activity.

In confirmation of the findings reported by Kusner et al. (20), we also demonstrated that PLD activation is required for ATP-induced BCG killing. It is therefore of interest that PLD has been implicated in a number of organelle trafficking functions, e.g., degranulation by mast cells (40) and endosome fusion (41). PLD activation produces increased levels of phosphatidic acid, a known fusogen to endosome membranes (41). PLD may also activate additional phospholipases such as phospholipase A2 (PLA2) (42, 43, 44, 45). Interestingly, PLA2 is known to be induced within ATP-treated macrophages (46). This in turn may then promote endosome fusion via the generation of arachidonic acid (47).

We hypothesize that BCG actively inhibit the fusigenicity of their phagosomes, thereby preventing phagosome maturation, i.e., lysosome fusion and acidification. One mechanism by which they may achieve this effect is by altering the lipid composition of their phagosome membranes. We propose that ATP might act to overcome this inhibition via the generation of fusinogenic mediators such as PLD and/or its downstream mediators, e.g., PLA2 and arachidonic acid that act to promote organelle fusion.

Further investigation of this intracellular bacterial killing mechanism may help to elucidate a key macrophage-mediated antimycobacterial effector process. In addition, the signaling pathway(s) involved may prove to be amenable to modulation via targeted drug design for the treatment of multidrug-resistant tuberculosis.

Footnotes

  • ↵1 I.P.F. is a Wellcome clinical research fellow.

  • ↵2 Address correspondence and reprint requests to Dr. Ian P. Fairbairn, Medical Research Council Centre for Immune Regulation, Birmingham Medical School, Birmingham University, Edgbaston, Birmingham, B15 2TT, U.K. E-mail address: i.p.fairbairn{at}bham.ac.uk

  • ↵3 Abbreviations used in this paper: Nramp1, natural resistance-associated macrophage protein 1; ADC, albumin dextrose catalase; BCG, bacille Calmette-Guérin; BMDM, bone marrow-derived macrophage; DAMP, 3-(2,4-dinitroanilino)-3′-amino-N-methyl dipropylamine; EM, electron microscopy; GFP, green fluorescent protein; iNOS, inducible NO synthase; L-NMMA, NG-monomethyl-L-arginine monoacetate; PLA2, phospholipase A2; PLD, phospholipase D; WT, wild type.

  • Received October 10, 2000.
  • Accepted July 10, 2001.
  • Copyright © 2001 by The American Association of Immunologists

References

  1. ↵
    Smith, P. E., A. R. Moss. 1994. Epidemiology of tuberculosis. B. R. Bloom, ed. Tuberculosis: Pathogenesis, Protection, and Control 47 Am. Soc. Microbiol., Washington, DC.
  2. ↵
    Pedersen, C., J. O. Nielsen. 1987. Tuberculosis in homosexual men with HIV disease. Scand. J. Infect. Dis. 19: 289
    OpenUrlCrossRefPubMed
  3. ↵
    Altare, F., D. Lammas, P. Revy, E. Jouanguy, R. Doffinger, S. Lamhamedi, P. Drysdale, D. Scheel-Toellner, J. Girdlestone, P. Darbyshire, et al 1998. Inherited interleukin 12 deficiency in a child with bacille Calmette-Guérin and Salmonella enteritidis disseminated infection. J. Clin. Invest. 102: 2035
    OpenUrlCrossRefPubMed
  4. ↵
    Jouanguy, E., F. Altare, S. Lamhamedi, P. Revy, J. F. Emile, M. Newport, M. Levin, S. Blanche, E. Seboun, A. Fischer, J. L. Casanova. 1996. Interferon-γ-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. N. Engl. J. Med. 335: 1956
    OpenUrlCrossRefPubMed
  5. ↵
    Sugawara, I., H. Yamada, H. Kaneko, S. Mizuno, K. Takeda, S. Akira. 1999. Role of interleukin-18 (IL-18) in mycobacterial infection in IL-18-gene-disrupted mice. Infect. Immun. 67: 2585
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Oppmann, B., R. Lesley, B. Blom, J. C. Timans, Y. Xu, B. Hunte, F. Vega, N. Yu, J. Wang, K. Singh, et al 2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13: 715
    OpenUrlCrossRefPubMed
  7. ↵
    Flynn, J. L., M. M. Goldstein, J. Chan, K. J. Triebold, K. Pfeffer, C. J. Lowenstein, R. Schreiber, T. W. Mak, B. R. Bloom. 1995. Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2: 561
    OpenUrlCrossRefPubMed
  8. ↵
    Manca, C., S. Paul, C. E. Barry, III, V. H. Freedman, G. Kaplan. 1999. Mycobacterium tuberculosis catalase and peroxidase activities and resistance to oxidative killing in human monocytes in vitro. Infect. Immun. 67: 74
    OpenUrlAbstract/FREE Full Text
  9. ↵
    Yu, K., C. Mitchell, Y. Xing, R. S. Magliozzo, B. R. Bloom, J. Chan. 1999. Toxicity of nitrogen oxides and related oxidants on mycobacteria: M. tuberculosis is resistant to peroxynitrite anion. Tuber. Lung Dis. 79: 191
    OpenUrlCrossRefPubMed
  10. ↵
    Hart, P. D., M. R. Young, A. H. Gordon, K. H. Sullivan. 1987. Inhibition of phagosome-lysosome fusion in macrophages by certain mycobacteria can be explained by inhibition of lysosomal movements observed after phagocytosis. J. Exp. Med. 166: 933
    OpenUrlAbstract/FREE Full Text
  11. ↵
    Clemens, D. L., M. A. Horwitz. 1995. Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited. J. Exp. Med. 181: 257
    OpenUrlAbstract/FREE Full Text
  12. ↵
    Reiner, N. E.. 1994. Altered cell signaling and mononuclear phagocyte deactivation during intracellular infection. Immunol. Today 15: 374
    OpenUrlCrossRefPubMed
  13. ↵
    Vidal, S., M. L. Tremblay, G. Govoni, S. Gauthier, G. Sebastiani, D. Malo, E. Skamene, M. Olivier, S. Jothy, P. Gros. 1995. The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene. J. Exp. Med. 182: 655
    OpenUrlAbstract/FREE Full Text
  14. ↵
    Gomes, M. S., R. Appelberg. 1998. Evidence for a link between iron metabolism and Nramp1 gene function in innate resistance against Mycobacterium avium. Immunology 95: 165
    OpenUrlCrossRefPubMed
  15. ↵
    Zwilling, B. S., D. E. Kuhn, L. Wikoff, D. Brown, W. Lafuse. 1999. Role of iron in Nramp1-mediated inhibition of mycobacterial growth. Infect. Immun. 67: 1386
    OpenUrlAbstract/FREE Full Text
  16. ↵
    Hackam, D. J., O. D. Rotstein, W. Zhang, S. Gruenheid, P. Gros, S. Grinstein. 1998. Host resistance to intracellular infection: mutation of natural resistance-associated macrophage protein 1 (Nramp1) impairs phagosomal acidification. J. Exp. Med. 188: 351
    OpenUrlAbstract/FREE Full Text
  17. ↵
    Sato, K., T. Akaki, H. Tomioka. 1998. Differential potentiation of anti-mycobacterial activity and reactive nitrogen intermediate-producing ability of murine peritoneal macrophages activated by interferon-γ (IFN-γ) and tumor necrosis factor-α (TNF-α). Clin. Exp. Immunol. 112: 63
    OpenUrlCrossRefPubMed
  18. ↵
    Rook, G. A., J. Taverne, C. Leveton, J. Steele. 1987. The role of γ-interferon, vitamin D3 metabolites and tumor necrosis factor in the pathogenesis of tuberculosis. Immunology 62: 229
    OpenUrlPubMed
  19. ↵
    Lammas, D. A., C. Stober, C. J. Harvey, N. Kendrick, S. Panchalingam, D. S. Kumararatne. 1997. ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z (P2X7) receptors. Immunity 7: 433
    OpenUrlCrossRefPubMed
  20. ↵
    Kusner, D. J., J. Adams. 2000. ATP-induced killing of virulent Mycobacterium tuberculosis within human macrophages requires phospholipase D. J. Immunol. 164: 379
    OpenUrlAbstract/FREE Full Text
  21. ↵
    Molloy, A., P. Laochumroonvorapong, G. Kaplan. 1994. Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guérin. J. Exp. Med. 180: 1499
    OpenUrlAbstract/FREE Full Text
  22. ↵
    Barton, C. H., S. H. Whitehead, J. M. Blackwell. 1995. Nramp transfection transfers Ity/Lsh/Bcg-related pleiotropic effects on macrophage activation: influence on oxidative burst and nitric oxide pathways. Mol. Med. 1: 267
    OpenUrlPubMed
  23. ↵
    Sikora, A., J. Liu, C. Brosnan, G. Buell, I. Chessel, B. R. Bloom. 1999. Cutting edge: purinergic signaling regulates radical-mediated bacterial killing mechanisms in macrophages through a P2X7-independent mechanism. J. Immunol. 163: 558
    OpenUrlAbstract/FREE Full Text
  24. ↵
    Tkalcevic, J., M. Novelli, M. Phylactides, J. P. Iredale, A. W. Segal, J. Roes. 2000. Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G. Immunity 12: 201
    OpenUrlCrossRefPubMed
  25. ↵
    Wei, X. Q., I. G. Charles, A. Smith, J. Ure, G. J. Feng, F. P. Huang, D. Xu, W. Muller, S. Moncada, F. Y. Liew. 1995. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375: 408
    OpenUrlCrossRefPubMed
  26. ↵
    Cormack, B. P., R. H. Valdivia, S. Falkow. 1996. FACS-optimized mutants of the green fluorescent protein (GFP). Gene 173: 33
    OpenUrlCrossRefPubMed
  27. ↵
    Snewin, V. A., M. P. Gares, P. O. Gaora, Z. Hasan, I. N. Brown, D. B. Young. 1999. Assessment of immunity to mycobacterial infection with luciferase reporter constructs. Infect. Immun. 67: 4586
    OpenUrlAbstract/FREE Full Text
  28. ↵
    Steinberg, T. H., J. A. Swanson, S. C. Silverstein. 1988. A prelysosomal compartment sequesters membrane-impermeant fluorescent dyes from the cytoplasmic matrix of J774 macrophages. J. Cell Biol. 107: 887
    OpenUrlAbstract/FREE Full Text
  29. ↵
    Crowle, A. J., R. Dahl, E. Ross, M. H. May. 1991. Evidence that vesicles containing living, virulent Mycobacterium tuberculosis or Mycobacterium avium in cultured human macrophages are not acidic. Infect. Immun. 59: 1823
    OpenUrlAbstract/FREE Full Text
  30. ↵
    Yang, S. F., S. Freer, A. A. Benson. 1967. Transphosphatidylation by phospholipase D. J. Biol. Chem. 242: 477
    OpenUrlAbstract/FREE Full Text
  31. ↵
    Malo, D., K. Vogan, S. Vidal, J. Hu, M. Cellier, E. Schurr, A. Fuks, N. Bumstead, K. Morgan, P. Gros. 1994. Haplotype mapping and sequence analysis of the mouse Nramp gene predict susceptibility to infection with intracellular parasites. Genomics 23: 51
    OpenUrlCrossRefPubMed
  32. ↵
    Sturgill-Koszycki, S., P. H. Schlesinger, P. Chakraborty, P. L. Haddix, H. L. Collins, A. K. Fok, R. D. Allen, S. L. Gluck, J. Heuser, D. G. Russell. 1994. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase: [Published erratum appears in 1994 Science 263:1359.]. Science 263: 678
    OpenUrlAbstract/FREE Full Text
  33. ↵
    Collo, G., S. Neidhart, E. Kawashima, M. Kosco-Vilbois, R. A. North, G. Buell. 1997. Tissue distribution of the P2X7 receptor. Neuropharmacology 36: 1277
    OpenUrlCrossRefPubMed
  34. ↵
    Berchtold, S., A. L. Ogilvie, C. Bogdan, P. Muhl-Zurbes, A. Ogilvie, G. Schuler, A. Steinkasserer. 1999. Human monocyte derived dendritic cells express functional P2X and P2Y receptors as well as ecto-nucleotidases. FEBS Lett. 458: 424
    OpenUrlCrossRefPubMed
  35. ↵
    Stober, C. B., D. A. Lammas, D. S. Kumararatne, S. L. Lightman, C. A. McArdle. 2001. ATP-mediated killing of Mycobacterium bovis bacille Calmette Guérin (BCG) within human macrophages is calcium-dependent and associated with the acidification of mycobacteria-containing phagosomes. J. Immunol. 166: 6276
    OpenUrlAbstract/FREE Full Text
  36. ↵
    Bellamy, R., C. Ruwende, T. Corrah, K. P. McAdam, H. C. Whittle, A. V. Hill. 1998. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N. Engl. J. Med. 338: 640
    OpenUrlCrossRefPubMed
  37. ↵
    Gruenheid, S., E. Pinner, M. Desjardins, P. Gros. 1997. Natural resistance to infection with intracellular pathogens: the Nramp1 protein is recruited to the membrane of the phagosome. J. Exp. Med. 185: 717
    OpenUrlAbstract/FREE Full Text
  38. ↵
    Piddington, D. L., A. Kashkouli, N. A. Buchmeier. 2000. Growth of Mycobacterium tuberculosis in a defined medium is very restricted by acid pH and Mg2+ levels. Infect. Immun. 68: 4518
    OpenUrlAbstract/FREE Full Text
  39. ↵
    Gomes, M. S., S. Paul, A. L. Moreira, R. Appelberg, M. Rabinovitch, G. Kaplan. 1999. Survival of Mycobacterium avium and Mycobacterium tuberculosis in acidified vacuoles of murine macrophages. Infect. Immun. 67: 3199
    OpenUrlAbstract/FREE Full Text
  40. ↵
    Brown, F. D., N. Thompson, K. M. Saqib, J. M. Clark, D. Powner, N. T. Thompson, R. Solari, M. J. Wakelam. 1998. Phospholipase D1 localizes to secretory granules and lysosomes and is plasma-membrane translocated on cellular stimulation. Curr. Biol. 8: 835
    OpenUrlCrossRefPubMed
  41. ↵
    Jones, A. T., M. J. Clague. 1997. Regulation of early endosome fusion by phospholipase D activity. Biochem. Biophys. Res. Commun. 236: 285
    OpenUrlCrossRefPubMed
  42. ↵
    Milella, M., A. Gismondi, P. Roncaioli, G. Palmieri, S. Morrone, M. Piccoli, L. Frati, M. G. Cifone, A. Santoni. 1999. β1 integrin cross-linking inhibits CD16-induced phospholipase D and secretory phospholipase A2 activity and granule exocytosis in human NK cells: role of phospholipase D in CD16-triggered degranulation. J. Immunol. 162: 2064
    OpenUrlAbstract/FREE Full Text
  43. ↵
    Kinkaid, A. R., R. Othman, J. Voysey, D. C. Wilton. 1998. Phospholipase D and phosphatidic acid enhance the hydrolysis of phospholipids in vesicles and in cell membranes by human secreted phospholipase A2. Biochim. Biophys. Acta 1390: 173
    OpenUrlPubMed
  44. ↵
    Bauldry, S. A., R. E. Wooten. 1997. Induction of cytosolic phospholipase A2 activity by phosphatidic acid and diglycerides in permeabilized human neutrophils: interrelationship between phospholipases D and A2. Biochem. J. 322: 353
    OpenUrlAbstract/FREE Full Text
  45. ↵
    Sato, T., T. Ishimoto, S. Akiba, T. Fujii. 1993. Enhancement of phospholipase A2 activation by phosphatidic acid endogenously formed through phospholipase D action in rat peritoneal mast cell. FEBS Lett. 323: 23
    OpenUrlCrossRefPubMed
  46. ↵
    Balboa, M. A., J. Balsinde, C. A. Johnson, E. A. Dennis. 1999. Regulation of arachidonic acid mobilization in lipopolysaccharide-activated P388D(1) macrophages by adenosine triphosphate. J. Biol. Chem. 274: 36764
    OpenUrlAbstract/FREE Full Text
  47. ↵
    Mayorga, L. S., M. I. Colombo, M. Lennartz, E. J. Brown, K. H. Rahman, R. Weiss, P. J. Lennon, P. D. Stahl. 1993. Inhibition of endosome fusion by phospholipase A2 (PLA2) inhibitors points to a role for PLA2 in endocytosis. Proc. Natl. Acad. Sci. USA 90: 10255
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

The Journal of Immunology: 167 (6)
The Journal of Immunology
Vol. 167, Issue 6
15 Sep 2001
  • Table of Contents
  • About the Cover
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
ATP-Mediated Killing of Intracellular Mycobacteria by Macrophages Is a P2X7-Dependent Process Inducing Bacterial Death by Phagosome-Lysosome Fusion
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
ATP-Mediated Killing of Intracellular Mycobacteria by Macrophages Is a P2X7-Dependent Process Inducing Bacterial Death by Phagosome-Lysosome Fusion
Ian P. Fairbairn, Carmel B. Stober, Dinakantha S. Kumararatne, David A. Lammas
The Journal of Immunology September 15, 2001, 167 (6) 3300-3307; DOI: 10.4049/jimmunol.167.6.3300

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
ATP-Mediated Killing of Intracellular Mycobacteria by Macrophages Is a P2X7-Dependent Process Inducing Bacterial Death by Phagosome-Lysosome Fusion
Ian P. Fairbairn, Carmel B. Stober, Dinakantha S. Kumararatne, David A. Lammas
The Journal of Immunology September 15, 2001, 167 (6) 3300-3307; DOI: 10.4049/jimmunol.167.6.3300
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Two Human Monoclonal HLA-Reactive Antibodies Cross-React with Mamu-B*008, a Rhesus Macaque MHC Allotype Associated with Control of Simian Immunodeficiency Virus Replication
  • The Crystal Structure of the MHC Class I (MHC-I) Molecule in the Green Anole Lizard Demonstrates the Unique MHC-I System in Reptiles
  • Structure and Functional Characterization of a Humanized Anti-CCL20 Antibody following Exposure to Serum Reveals the Formation of Immune Complex That Leads to Toxicity
Show more MOLECULAR AND STRUCTURAL IMMUNOLOGY

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606